Winston & Strawn and Taylor Wessing UK to Combine, Creating a Premier Transatlantic Law Firm
15.12.2025 16:52:00 CET | Business Wire | Press Release
Winston & Strawn and Taylor Wessing’s UK-led business announced today their intention to combine, creating a premier transatlantic law firm that would operate under a new shared name, Winston Taylor. The combination responds to increasing client demand for seamlessly integrated US–UK–EU counsel for the businesses, people, and markets driving capital and innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215914957/en/
The combination once final will unite two international firms with more than 400 years of combined history, complementary strengths, and a common vision to meet clients’ evolving global needs. The combined firm will include more than 1,400 lawyers, establishing one of the largest transatlantic firms whose footprint is primarily in the United States, the United Kingdom, and Europe, and also in Latin America and the Middle East.
Leveraging significant strength and scale in major litigation, critical transactions, strategic IP, and private wealth, Winston Taylor will deliver best-in-class client service across key sectors including technology, life sciences, and financial services. Clients will gain a unified team with end-to-end capabilities across jurisdictions to achieve their business objectives in the breakthrough moments across their lifecycle.
“Once combined, we will have a London-headquartered partner that fulfills our long-held ambition to grow in the UK, while preserving the culture, agility, focus, and relentless client service that define Winston & Strawn,” said Steve D’Amore, Chairman of Winston & Strawn, who will continue as Chairman of the combined firm. “This combination will establish an elite practice in the major commercial centers important to our clients. Winston Taylor will be positioned to lead on the most sophisticated litigation and transactions in the world’s most defining industries.”
"In Winston & Strawn, Taylor Wessing UK will have a US partner that shares our vision, our values, and culture, and absolute focus on the highest levels of client service," said Shane Gleghorn, Managing Partner of Taylor Wessing UK, who will serve as Managing Partner of Europe and Middle East for Winston Taylor and will become a member of its Executive Committee. "By combining Winston & Strawn’s strength in the major hubs across the United States with our coverage of the key centers of London, Europe, and the Middle East we will have created a firm with the highest level of transatlantic capabilities in key practices and sectors."
Winston Taylor, once formed, will bring together two firms with aligned practices, shared clients, and cultures rooted in innovation and exceptional client service. The combined firm’s expanded corporate, private equity, real estate, finance, antitrust, regulatory, and private wealth capabilities will provide clients with end-to-end global business strategy and support. In addition, the combination of Taylor Wessing UK’s Tier 1 UK–EU holistic IP practice with Winston & Strawn’s premier U.S. intellectual property litigation practice will establish a market-leading transatlantic IP platform.
As part of the combination, Taylor Wessing the Netherlands and Belgium will enter into an agreement with Winston Taylor to operate under the Winston Taylor brand.
Completion of the combination is expected in May 2026, subject to approvals and a vote of the partners in each firm. Until then, they will operate as separate firms in the normal course. Upon closing, Taylor Wessing UK and Taylor Wessing the Netherlands and Belgium would depart the Taylor Wessing verein and Winston Taylor would seek to have a cooperation and referral relationship with the Taylor Wessing verein to provide continuity of support to clients.
Notes to editors
The combined business will have 20 offices in Amsterdam, Brussels, Cambridge, Charlotte, Chicago, Dallas, Dubai, Dublin, Eindhoven, Houston, Liverpool, London, Los Angeles, Miami, New York, Paris, San Francisco, São Paulo, Silicon Valley, and Washington DC.
For more information, visit www.winstontaylor.com.
AboutWinston & Strawn
Founded in 1853, Winston & Strawn is an Am Law 50 firm with ~1,000 lawyers across 14 offices worldwide. The firm is recognized for its leadership in litigation, intellectual property, corporate and finance transactions, and regulatory work across major sectors, including technology, life sciences, and financial services.
About Taylor Wessing UK
Founded in 1782, Taylor Wessing UK is a Top 20 UK law firm with over 450 lawyers in the UK, Ireland and the Middle East. The firm is renowned for its Tier 1 intellectual property, life sciences, technology, and private wealth practices, advising clients ranging from global corporations to leading innovators and investors.
About Taylor Wessing the Netherlands and Belgium
Taylor Wessing the Netherlands and Belgium brings together its Amsterdam, Eindhoven, and Brussels offices into a fully integrated Benelux practice, with over 100 lawyers and civil-law notaries advising high-growth technology and life sciences companies, multinational corporates, and investors on corporate transactions, intellectual property, disputes, and regulatory matters.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251215914957/en/
Contacts
WinstonTaylor@infiniteglobal.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma’s Morcamilast (ME3183) was Granted Orphan Medicinal Product Designation by the European Commission for Palmoplantar Pustulosis3.3.2026 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that morcamilast (proposed international nonproprietary name; development code: ME3183), a selective phosphodiesterase-4 (PDE4) inhibitor, has been granted orphan medicinal product designation by the European Commission (EC) for the treatment of palmoplantar pustulosis (PPP). Palmoplantar pustulosis is a chronic inflammatory disease characterized by the development of multiple sterile pustules on the palms and soles. Patients often experience pain and pruritus of the skin, and the condition can be accompanied by nail involvement and joint pain. Because lesions on the palms are visible to others and lesions on the soles can cause pain while walking, daily functioning can be significantly restricted, leading in a substantial reduction in quality of life. PPP has a pathophysiology distinct from psoriasis and pustular psoriasis, and treatment can be challenging, unde
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth3.3.2026 01:00:00 CET | Press Release
Yubico (NASDAQ STOCKHOLM: YUBICO), a cybersecurity company, inventor of FIDO passkeys and creator of the YubiKey, the most secure passkey, today announced the opening of its third global headquarters in Singapore. This announcement reinforces Yubico’s long-term commitment to the Asia Pacific region and builds on its role in advancing open authentication standards, while shaping a safer digital world for all. The new office complements Yubico’s existing global headquarters in Stockholm, Sweden and Santa Clara, USA, reflecting its strategy to serve a growing international user base by helping customers deploy YubiKeys at scale to adapt to a rapidly evolving cybersecurity landscape. “As the digital economy grows, there’s a decisive shift across Asia Pacific, where organizations are moving beyond legacy multi-factor authentication to meet rigorous new national regulations for identity protection,” said Jerrod Chong, Acting Chief Executive Officer at Yubico, a Singaporean. “The expansion of
IFF Completed the Divestiture of Soy Crush, Concentrates and Lecithin Businesses2.3.2026 22:15:00 CET | Press Release
IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its soy crush, concentrates and lecithin businesses to Bunge. This transaction does not include IFF’s soy isolates business. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in taste, scent, food ingredients, health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20260302231096/en/
Verimatrix ReAccess Earns Gold 2026 Merit Award for Telecom & Wireless2.3.2026 17:50:00 CET | Press Release
Regulatory News: Verimatrix (Euronext Paris: VMX), a leading provider of security solutions for a safer connected world, today announced that its Verimatrix ReAccess solution was honored with a gold 2026 Merit Award for Telecom & Wireless. The industry accolade recognizes the company’s next-generation content security solution that modernizes legacy Conditional Access Systems (CAS) across DVB, IPTV and OTT networks without requiring costly hardware replacements or field service interventions. Judged by industry executives, media professionals and technology consultants, the Merit Awards evaluate submissions from across the telecommunications landscape. Verimatrix ReAccess enables secure, over-the-air (OTA) software updates to deployed set-top boxes (STBs), delivering operator cost savings, reduced operational complexity, and ongoing protection against piracy. It also empowers operators to continuously strengthen content security, eliminating the need for costly hardware replacements. U
Textron Aviation Launches Donation Campaign to Support 2026 Special Olympics Airlift; Continues Nationwide Call for Volunteer Doves2.3.2026 17:00:00 CET | Press Release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, today announced the launch of a donation campaign benefitting Special Olympics in support of the 2026 Special Olympics Airlift, a nationwide effort that brings athletes and coaches to the Special Olympics USA Games through the generosity of volunteer pilots, aircraft owners and operators known as Doves. Financial contributions go directly to the Special Olympics, a 501(c)(3) charitable organization. New for the 2026 event, the donation campaign serves a vital role in ensuring each delegation has what it needs for a smooth and welcoming travel experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302196418/en/ Textron Aviation launches donation campaign to support 2026 Special Olympics Airlift; continues nationwide call for volunteer Doves (Photo credit: Textron Aviation). “This campaign reflects the spirit of unity and generosity that defines the Special Olym
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom